Gonadotropin therapy to treat specific male infertility disorders associated with
hypogonadotropic hypogonadism is evidence-based and effective in restoring …

BACKGROUND The beneficial effects of hormonal therapy in stimulating spermatogenesis
in patients with non-obstructive azoospermia (NOA) and either normal gonadotrophins or …

Infertility affects 15% of couples worldwide and in approximately 50% of cases the cause is
secondary to an abnormality of the sperm. However, treatment options for male infertility are …

INTRODUCTION male infertility affects 15% of couples, with azoospermia diagnosed among
1% of the general male population and 10–15% of males presenting with infertility. Use of …

Except in cases of hypogonadotropic hypogonadism, the use of medical therapy before
microsurgical testicular sperm extraction (micro-TESE) is controversial. In some studies …

Résumé Contexte Les traitements de stimulation de la spermatogenèse et les compléments
alimentaires à visée anti-oxydante sont souvent proposés aux patients infertiles soit avant …

Male infertility affects 15% of couples, with azoospermia diagnosed among 1% of the
general male population and 10–15% of males presenting with infertility. Use of well-defined …

L'infertilité masculine affecte 15% des couples, une azoospermie étant diagnostiquée chez
1% de la population masculine générale et chez 10 à 15% des hommes infertiles. Grâce à …